000 01203 a2200349 4500
005 20250512005111.0
264 0 _c19890919
008 198909s 0 0 eng d
022 _a0770-3198
024 7 _a10.1007/BF02030079
_2doi
040 _aNLM
_beng
_cNLM
100 1 _ade Rooij, D J
245 0 0 _aMarker antibodies in scleroderma and polymyositis: clinical associations.
_h[electronic resource]
260 _bClinical rheumatology
_cJun 1989
300 _a231-7 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntibody Specificity
650 0 4 _aAutoantibodies
_xanalysis
650 0 4 _aCentromere
_ximmunology
650 0 4 _aDNA Topoisomerases, Type I
_ximmunology
650 0 4 _aDermatomyositis
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunoblotting
650 0 4 _aMyositis
_ximmunology
650 0 4 _aScleroderma, Systemic
_xclassification
650 0 4 _aSyndrome
700 1 _aVan de Putte, L B
700 1 _aHabets, W J
700 1 _aVan Venrooij, W J
773 0 _tClinical rheumatology
_gvol. 8
_gno. 2
_gp. 231-7
856 4 0 _uhttps://doi.org/10.1007/BF02030079
_zAvailable from publisher's website
999 _c2553501
_d2553501